Copyright Reports & Markets. All rights reserved.

Global Point-of-Care Molecular Diagnostics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Point-of-Care Molecular Diagnostics Market Overview

    • 1.1 Product Overview and Scope of Point-of-Care Molecular Diagnostics
    • 1.2 Classification of Point-of-Care Molecular Diagnostics by Types
      • 1.2.1 Global Point-of-Care Molecular Diagnostics Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Types in 2018
      • 1.2.3 PCR-based
      • 1.2.4 Genetic Sequencing-based
      • 1.2.5 Hybridization-based
      • 1.2.6 Microarray-based
    • 1.3 Global Point-of-Care Molecular Diagnostics Market by Application
      • 1.3.1 Global Point-of-Care Molecular Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Infectious Diseases
      • 1.3.3 Oncology
      • 1.3.4 Hematology
      • 1.3.5 Prenatal Testing
      • 1.3.6 Endocrinology
      • 1.3.7 Other
    • 1.4 Global Point-of-Care Molecular Diagnostics Market by Regions
      • 1.4.1 Global Point-of-Care Molecular Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Point-of-Care Molecular Diagnostics (2014-2024)

    2 Company Profiles

    • 2.1 Danaher Corporation
      • 2.1.1 Business Overview
      • 2.1.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Danaher Corporation Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Johnson and Johnson
      • 2.2.1 Business Overview
      • 2.2.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Johnson and Johnson Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 BioMerieux
      • 2.3.1 Business Overview
      • 2.3.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 BioMerieux Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 F. Hoffmann-La Roche AG
      • 2.4.1 Business Overview
      • 2.4.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Abbott Laboratories, Bayer Healthcare
      • 2.5.1 Business Overview
      • 2.5.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Becton, Dickinson and Company
      • 2.6.1 Business Overview
      • 2.6.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Cepheid, Inc.
      • 2.7.1 Business Overview
      • 2.7.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Cepheid, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bio-Rad Laboratories, Inc.
      • 2.8.1 Business Overview
      • 2.8.2 Point-of-Care Molecular Diagnostics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Point-of-Care Molecular Diagnostics Market Competition, by Players

    • 3.1 Global Point-of-Care Molecular Diagnostics Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Point-of-Care Molecular Diagnostics Players Market Share
      • 3.2.2 Top 10 Point-of-Care Molecular Diagnostics Players Market Share
    • 3.3 Market Competition Trend

    4 Global Point-of-Care Molecular Diagnostics Market Size by Regions

    • 4.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Regions
    • 4.2 North America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.5 South America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

    5 North America Point-of-Care Molecular Diagnostics Revenue by Countries

    • 5.1 North America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
    • 5.2 USA Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

    6 Europe Point-of-Care Molecular Diagnostics Revenue by Countries

    • 6.1 Europe Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
    • 6.2 Germany Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.3 UK Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.4 France Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries

    • 7.1 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
    • 7.2 China Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.5 India Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

    8 South America Point-of-Care Molecular Diagnostics Revenue by Countries

    • 8.1 South America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
    • 8.2 Brazil Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Point-of-Care Molecular Diagnostics by Countries

    • 9.1 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

    10 Global Point-of-Care Molecular Diagnostics Market Segment by Type

    • 10.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Point-of-Care Molecular Diagnostics Market Forecast by Type (2019-2024)
    • 10.3 PCR-based Revenue Growth Rate (2014-2024)
    • 10.4 Genetic Sequencing-based Revenue Growth Rate (2014-2024)
    • 10.5 Hybridization-based Revenue Growth Rate (2014-2024)
    • 10.6 Microarray-based Revenue Growth Rate (2014-2024)

    11 Global Point-of-Care Molecular Diagnostics Market Segment by Application

    • 11.1 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2014-2019)
    • 11.2 Point-of-Care Molecular Diagnostics Market Forecast by Application (2019-2024)
    • 11.3 Infectious Diseases Revenue Growth (2014-2019)
    • 11.4 Oncology Revenue Growth (2014-2019)
    • 11.5 Hematology Revenue Growth (2014-2019)
    • 11.6 Prenatal Testing Revenue Growth (2014-2019)
    • 11.7 Endocrinology Revenue Growth (2014-2019)
    • 11.8 Other Revenue Growth (2014-2019)

    12 Global Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2024)

    • 12.1 Global Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2024)
    • 12.2 Global Point-of-Care Molecular Diagnostics Market Forecast by Regions (2019-2024)
    • 12.3 North America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
    • 12.4 Europe Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
    • 12.6 South America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global Point-of-Care Molecular Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Point-of-Care Molecular Diagnostics.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Point-of-Care Molecular Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Point-of-Care Molecular Diagnostics market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Danaher Corporation
      Johnson and Johnson
      BioMerieux
      F. Hoffmann-La Roche AG
      Abbott Laboratories, Bayer Healthcare
      Becton, Dickinson and Company
      Cepheid, Inc.
      Bio-Rad Laboratories, Inc.

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      PCR-based
      Genetic Sequencing-based
      Hybridization-based
      Microarray-based

      Market Segment by Applications, can be divided into
      Infectious Diseases
      Oncology
      Hematology
      Prenatal Testing
      Endocrinology
      Other
      Buy now